Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 242 results:
Συντάκτης Τίτλος [ Τύπος] Έτος Φίλτρα: Συντάκτης is Kountouras, Jannis [Clear All Filters]
Prevalence, bowel habit subtypes and medical care-seeking behaviour of patients with irritable bowel syndrome in Northern Greece..
Eur J Gastroenterol Hepatol. 21(2), 183-9.
(2009). A proposed role of human defensins in Helicobacter pylori-related neurodegenerative disorders..
Med Hypotheses. 82(3), 368-73.
(2014). A prospective comparative study of blended and pure coagulation current in endoscopic mucosal resection of large sessile colorectal polyps..
Surg Laparosc Endosc Percutan Tech. 24(3), 226-31.
(2014). Prospective randomized study comparing double layer and Tannenbaum stents in distal malignant biliary stenosis..
Acta Gastroenterol Belg. 73(4), 445-50.
(2010). A rebuttal to the potential anti-tumour benefit of Helicobacter pylori-induced neutrophil-activating protein..
Cancer Immunol Immunother. 61(3), 445-6; discussion 447-51.
(2012). Recurrent acute pancreatitis caused by intra-ampullary carcinoid tumor..
Gastrointest Endosc. 69(7), 1387-8; discussion 1388.
(2009). Relationship between Helicobacter pylori infection and autoimmune disorders..
Clin Chem Lab Med. 51(5), e73-4.
(2013). Relationship between Helicobacter pylori infection and multiple sclerosis..
Ann Gastroenterol. 28(3), 353-356.
(2015). The relationship between -related microbiota dysbiosis and gastrointestinal tract pathologies..
Scand J Gastroenterol. 1-2.
(2019). Response to letter to the editor of Carcinogenesis by Li et al., 2020..
Carcinogenesis. 41(4), 539-540.
(2020). A retrospective comparative study of argon plasma versus polypectome snare tip coagulation: effect on recurrence rate after resection of large laterally spreading type lesions..
Ann Gastroenterol. 32(2), 178-184.
(2019). Review: Impact of Helicobacter pylori on Alzheimer's disease: What do we know so far?.
Helicobacter. 23(1),
(2018). Risk factors for therapeutic ERCP-related complications: an analysis of 2,715 cases performed by a single endoscopist..
Ann Gastroenterol. 27(1), 65-72.
(2014). Rodent models of obesity..
Minerva Endocrinol. 45(3), 243-263.
(2020). The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease..
Diabetes Obes Metab. 12(5), 365-83.
(2010). Role of autophagy in gastric carcinogenesis..
World J Gastrointest Oncol. 13(10), 1244-1262.
(2021). The role of capsule endoscopy in the evaluation and treatment of obscure-overt gastrointestinal bleeding during daily clinical practice: a prospective multicenter study..
Scand J Gastroenterol. 49(7), 862-70.
(2014). Selenium and selenoprotein P in nonalcoholic fatty liver disease..
Hormones (Athens). 19(1), 61-72.
(2020). Selenoprotein P in Patients with Nonalcoholic Fatty Liver Disease..
Exp Clin Endocrinol Diabetes.
(2019). Sequential or simultaneous placement of self-expandable metallic stents for palliation of malignant biliary and duodenal obstruction due to unresectable pancreatic head carcinoma..
Surg Laparosc Endosc Percutan Tech. 20(6), 410-5.
(2010). Serum homocysteine levels in patients with nonalcoholic fatty liver disease..
Ann Hepatol. 11(1), 68-76.
(2012). Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis..
Metabolism. 60(3), 313-26.
(2011). Serum visfatin in nonalcoholic fatty liver disease..
Ann Hepatol. 13(1), 150-1.
(2013). Serum vitamin B12 and folate levels in patients with non-alcoholic fatty liver disease..
Int J Food Sci Nutr. 63(6), 659-66.
(2012). Sex steroids and sex hormone-binding globulin in postmenopausal women with nonalcoholic fatty liver disease..
Hormones (Athens). 12(3), 405-16.
(2013).